| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6259987
[patent_doc_number] => 20020187502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Method of detection and treatment of colon cancer'
[patent_app_type] => new
[patent_app_number] => 10/134092
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19131
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10134092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/134092 | Method of detection and treatment of colon cancer | Apr 24, 2002 | Issued |
Array
(
[id] => 6329304
[patent_doc_number] => 20020198167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Uses of human UDP-glucuronosyltransferase 2B7 to detect and treat cancer'
[patent_app_type] => new
[patent_app_number] => 10/132499
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5201
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10132499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/132499 | Uses of human UDP-glucuronosyltransferase 2B7 to detect and treat cancer | Apr 24, 2002 | Issued |
Array
(
[id] => 644995
[patent_doc_number] => 07118862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Induction of apoptosis by cellular stress'
[patent_app_type] => utility
[patent_app_number] => 10/125003
[patent_app_country] => US
[patent_app_date] => 2002-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17626
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/118/07118862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125003 | Induction of apoptosis by cellular stress | Apr 17, 2002 | Issued |
Array
(
[id] => 887612
[patent_doc_number] => 07348139
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-03-25
[patent_title] => 'SOCS-1 gene methylation in cancer'
[patent_app_type] => utility
[patent_app_number] => 10/123882
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29167
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/348/07348139.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123882
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123882 | SOCS-1 gene methylation in cancer | Apr 14, 2002 | Issued |
| 10/111257 | Nucleic acid sequences of hyperplasia and tumours of the thyroid | Apr 10, 2002 | Abandoned |
Array
(
[id] => 6258700
[patent_doc_number] => 20020187149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Wound healing'
[patent_app_type] => new
[patent_app_number] => 10/117351
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5954
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117351
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117351 | Wound healing | Apr 7, 2002 | Abandoned |
| 60/453706 | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells | Apr 4, 2002 | Pending |
Array
(
[id] => 488891
[patent_doc_number] => 07214498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Tumor associated antigens and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/106559
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14552
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10106559
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/106559 | Tumor associated antigens and methods of using the same | Mar 24, 2002 | Issued |
Array
(
[id] => 91329
[patent_doc_number] => 07731959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Antagonists of neuropilin receptor function and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/104440
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 43
[patent_no_of_words] => 17504
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/731/07731959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104440 | Antagonists of neuropilin receptor function and use thereof | Mar 21, 2002 | Issued |
Array
(
[id] => 7306797
[patent_doc_number] => 20040116658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Human KAP/Cdi1-related gene variant associated with small cell lung cancer'
[patent_app_type] => new
[patent_app_number] => 10/103957
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6782
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116658.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103957
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103957 | Human KAP/Cdi1-related gene variant associated with small cell lung cancer | Mar 21, 2002 | Abandoned |
Array
(
[id] => 92505
[patent_doc_number] => 07737258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-15
[patent_title] => 'Uses of monoclonal antibody 8H9'
[patent_app_type] => utility
[patent_app_number] => 10/097558
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 37
[patent_no_of_words] => 56688
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/737/07737258.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097558
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097558 | Uses of monoclonal antibody 8H9 | Mar 7, 2002 | Issued |
Array
(
[id] => 5844264
[patent_doc_number] => 20020132262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/094474
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14848
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132262.pdf
[firstpage_image] =>[orig_patent_app_number] => 10094474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/094474 | Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof | Mar 7, 2002 | Issued |
Array
(
[id] => 6710973
[patent_doc_number] => 20030170722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Methods and reagents for regulating apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/090440
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20959
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170722.pdf
[firstpage_image] =>[orig_patent_app_number] => 10090440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/090440 | Methods and reagents for regulating apoptosis | Mar 3, 2002 | Abandoned |
| 10/069763 | Method for identifying an individual at risk for vascular and cancer disease | Feb 25, 2002 | Abandoned |
| 09/958571 | Recombinant protein uk114 and its use in therapy and diagnostics | Feb 24, 2002 | Abandoned |
Array
(
[id] => 5905054
[patent_doc_number] => 20020142005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction'
[patent_app_type] => new
[patent_app_number] => 10/081185
[patent_app_country] => US
[patent_app_date] => 2002-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7543
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081185
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081185 | Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction | Feb 24, 2002 | Abandoned |
Array
(
[id] => 6111110
[patent_doc_number] => 20020172987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Methods and reagents for the rapid and efficient isolation of circulating cancer cells'
[patent_app_type] => new
[patent_app_number] => 10/079939
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 29306
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20020172987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10079939
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/079939 | Methods and reagents for the rapid and efficient isolation of circulating cancer cells | Feb 18, 2002 | Abandoned |
Array
(
[id] => 6110984
[patent_doc_number] => 20020172957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Compositions and methods relating to lung specific genes and proteins'
[patent_app_type] => new
[patent_app_number] => 09/989920
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58300
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20020172957.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989920 | Compositions and methods relating to lung specific genes and proteins | Feb 12, 2002 | Abandoned |
Array
(
[id] => 5786374
[patent_doc_number] => 20020160007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Association of mhc class II allenles and cancer'
[patent_app_type] => new
[patent_app_number] => 10/049251
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5919
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10049251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/049251 | Association of mhc class II allenles and cancer | Feb 7, 2002 | Abandoned |
Array
(
[id] => 501692
[patent_doc_number] => 07205392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => 'Histidine-rich glycoprotein'
[patent_app_type] => utility
[patent_app_number] => 10/067093
[patent_app_country] => US
[patent_app_date] => 2002-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 13102
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/205/07205392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067093
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067093 | Histidine-rich glycoprotein | Feb 3, 2002 | Issued |